December 18, 2014 11:49 AM ET


Company Overview of FORMA Therapeutics, Inc.

Company Overview

FORMA Therapeutics, Inc. discovers and develops medicines in cancer and other genetically-driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company has a strategic partnership with Celgene Corporation. FORMA Therapeutics, Inc. was formerly known as Forma Pharmaceuticals, Inc. and changed its name to FORMA Therapeutics, Inc. in February 2008. The company was incorporated in 2007 and is based in Watertown, Massachusetts. It has additional chemistry operations in Branford, Connecticut.

500 Arsenal Street

Suite 100

Watertown, MA 02472

United States

Founded in 2007





Key Executives for FORMA Therapeutics, Inc.

Co-Founder and Director
Co-Founder and Vice President of Discovery Biology
Age: 52
Chief Financial Officer
Chief Operating Officer
Age: 50
Compensation as of Fiscal Year 2014.

FORMA Therapeutics, Inc. Key Developments

FORMA Therapeutics Appoints Marsha H. Fanucci as Board of Director

FORMA Therapeutics announced the appointment of Marsha H. Fanucci, former Senior Vice President and Chief Financial Officer of Millennium Pharmaceuticals to the company's Board of Directors. Since February 2014, Ms. Fanucci has served as Senior Financial Advisor to FORMA, contributing to strategic and operational financial planning. She will also serve as Chair of FORMA's Audit Committee.

FORMA Therapeutics Appoints Helen Boudreau as Chief Financial Officer

FORMA Therapeutics announced that Helen M. Boudreau has been appointed to the position of Chief Financial Officer. For the past six years, Helen has served at Novartis, most recently as Chief Financial Officer, Novartis Corporation, where she was responsible for treasury, tax, insurance, investor relations, the Finance Shared Service Center and financial management for corporate entities within the United States.

FORMA Therapeutics, Inc. Presents at Boston Biotech NY/NJ CEO Conference, Nov-12-2014 10:05 AM

FORMA Therapeutics, Inc. Presents at Boston Biotech NY/NJ CEO Conference, Nov-12-2014 10:05 AM. Venue: Apella, 450 East 29th Street, New York, New York, United States. Speakers: Steven Tregay, Co-Founder, Chief Executive Officer, President and Director.

Similar Private Companies By Industry

Company Name Region
Cytomatrix United States
Ginkgo BioWorks, Inc. United States
Atterocor, Inc. United States
Aviva Systems Biology LLC United States
Protea Biosciences, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FORMA Therapeutics, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at